ProShares Ultra NASDAQ Biotechnology
30 hedge funds and large institutions have $26M invested in ProShares Ultra NASDAQ Biotechnology in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 4 closing their positions.
Holders
30
Holders Change
+3
Holders Change %
+11.11%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
8
Reduced
9
Closed
4
Calls
$22.2M
Puts
$11.8M
Net Calls
+$10.4M
Net Calls Change
+$469K